Caffeine is a drug that may reduce brain injury in the setting of a disease called hypoxic-ischemic encephalopathy. This is a research study to determine the most appropriate and safest dose of caffeine in infants with hypoxic-ischemic encephalopathy.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Wesley Jackson
Neonatal-Perinatal Medicine
Clinical or Medical
Interventional
Child and Teen Health
Rare Diseases
24-0654
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
